Pasar al contenido principal

MEJORA DE LA PROTECCION NEURONAL Y CEREBRAL EN EL ICTUS MEDIANTE TECNICAS AVANZADAS DE ADMINISTRACION DE PEPTIDOS PENETRANTES DERIVADOS DE TRKB Y PSD-95

PID2022-137710OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A brain-accessible peptide modulates stroke inflammatory response and neurotoxicity by targeting BDNF-receptor TrkB-T1 specific interactome

  • Ugalde-Triviño, Lola
  • Tejeda, Gonzalo S.
  • Esteban-Ortega, Gema M.
  • Díaz-Guerra, Margarita
[Methods]: We designed cell-penetrating peptides containing TrkB-T1 isoform-specific sequences to: 1) characterize peptide delivery into rat primary cortical cultures and mice brain cortex; 2) isolate and identify the isoform interactome in basal and in vitro excitotoxic conditions; 3) analyze peptide effects on neuroinflammation and neurotoxicity using primary cultures subjected to excitotoxicity or in vivo in a mouse model of ischemia., [Results]: We identify here the TrkB-T1-specific interactome, poorly described to date, and demonstrate that interference of these protein-protein interactions using brain-accessible TrkB-T1-derived peptides can reduce reactive gliosis and decrease excitotoxicity-induced damage in cellular and animal models of stroke, where treatment reduces the infarct volume in male and female mice., [Conclusions]: The crucial role of TrkB-T1 in modulating microglia and astrocyte reactivity indicates that isoform-derived peptides hold promise for the development of therapies for human stroke and other excitotoxicity-associated pathologies., We acknowledge funding from Agencia Estatal de Investigación (PID2019-105784RB-100/AEI/10.13039/501100011033/FEDER, UE). These results are also part of project PID2022-137710OB-I00 funded by MICIU/AEI/10.13039/501100011033/FEDER, UE. The cost of publication has been paid in part by FEDER funds. A contract was funded associated to project PID2019-105784RB-100 (G.M.E-O) and L.U-T. was recipient of fellowships from Spanish Ministry of Universities "Ayuda del Programa de Formación de Profesorado Universitario" with code FPU22/01248 (2024-2028) and "Ayuda para el Fomento de la Investigación en Estudios de Master-UAM" fellowship from Universidad Autónoma de Madrid (2021-2022)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Retrograde transport of neurotrophin receptor TrkB-FL induced by excitotoxicity regulates Golgi stability and is a target for stroke neuroprotection

  • Esteban-Ortega, Gema M.
  • Torres-Campos, Elena
  • Díaz-Guerra, Margarita
Excitotoxicity, aberrant function of survival pathways dependent on brain-derived neurotrophic factor (BDNF), and disruption of the Golgi complex are shared pathological hallmarks in relevant neurological diseases, including stroke. However, the precise interdependence among these mechanisms is not completely defined, knowledge essential for developing neuroprotective strategies. For ischemic stroke, a leading cause of death, disability, and dementia, interfering with excitotoxicity—the major mechanism of neuronal death in the penumbra area—has shown promising results. We are exploring neuroprotection by promoting survival cascades dependent on the BDNF receptor, full-length tropomyosin-related kinase B (TrkB-FL), as these pathways become aberrant after excitotoxicity. We previously developed MTFL457, a blood-brain barrier (BBB) permeable neuroprotective peptide containing a TrkB-FL sequence, which efficiently prevents excitotoxicity-induced receptor processing and preserves BDNF-dependent pathways in an ischemia model, where it decreases infarct size and improves neurological outcome. In this work, using cellular and animal models, we demonstrate that excitotoxicity-induced TrkB-FL downregulation is secondary to receptor endocytosis, interaction with the endosomal protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), retrograde transport to the Golgi, and subsequent disruption of this organelle. Interestingly, peptide MTFL457 interferes with the TrkB-FL/Hrs interaction and receptor trafficking—processes required for excitotoxic Golgi fragmentation and TrkB-FL cleavage—demonstrating a central role for TrkB-FL in controlling Golgi stability. These results suggest the potential for peptide MTFL457 to preserve the function of this organelle and critical neuronal survival pathways in stroke and possibly other neurodegenerative diseases associated with excitotoxicity., The results are part of projects PID2019-105784RB-100 and PID2022-137710OB-I00 funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033/FEDER). GME-O and ET-C were supported, respectively, by contracts included in PID2019-105784RB-100 and PID2022-137710OB-I00 projects., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Neuroprotection against cochlear synaptopathy and noise-induced hearing loss by a TrkB-FL-derived cell-penetrating peptide

  • Torres-Campos, Elena
  • Varela-Nieto, Isabel
  • Díaz-Guerra, Margarita
[EN] Noise-induced hearing loss (NIHL) is the second leading cause of deafness globally. However, effective pharmacological treatments remain unavailable. Excitotoxicity, an early NIHL event, is a central mechanism in degeneration of cochlear synapses established between inner hair cells and spiral ganglion neurons. This excitotoxic damage can trigger the degradation of the neurotrophic TrkB receptor, thereby inhibiting brain-derived neurotrophic factor (BDNF) signaling and challenging neurotrophin-based therapies for hearing loss. Here, we evaluate the therapeutic potential in the inner ear of MTFL457, a cell-penetrating peptide that prevents TrkB-FL degradation during brain excitotoxicity. This peptide efficiently distributes through cochlear cells in both ex vivo (explants) and in vivo (noise-overexposed) models. In explants undergoing excitotoxicity, MTFL457 prevents TrkB-FL dysregulation, recovers downstream prosurvival signaling, and reduces neurodegeneration and cochlear synaptopathy. Furthermore, despite sexual dimorphism in noise damage susceptibility in vivo, MTFL457 preserves hearing function and synapses, demonstrating its therapeutic potential for NIHL and possibly other types of sensorineural hearing loss likewise associated with excitotoxicity., [ES] La pérdida auditiva inducida por ruido (NIHL, por sus siglas en inglés) constituye la segunda causa más frecuente de sordera a nivel mundial. No obstante, en la actualidad no se dispone de tratamientos farmacológicos eficaces. La excitotoxicidad, un evento temprano en la NIHL, representa un mecanismo central en la degeneración de las sinapsis cocleares establecidas entre las células ciliadas internas y las neuronas del ganglio espiral. Este daño excitotóxico puede desencadenar la degradación del receptor neurotrófico TrkB, inhibiendo así las vías de señalización mediadas por el factor neurotrófico derivado del cerebro (BDNF) y limitando la eficacia de las terapias para la pérdida auditiva basadas en neurotrofinas. En este estudio, evaluamos el potencial terapéutico en el oído interno de MTFL457, un péptido capaz de penetrar en las células, que previene la degradación de la isoforma completa del receptor TrkB (TrkB-FL) durante procesos de excitotoxicidad cerebral. Este péptido se distribuye eficazmente en las células cocleares tanto en modelos ex vivo (explantes) como in vivo (exposición excesiva al ruido). En explantes sometidos a excitotoxicidad, MTFL457 previene la desregulación de TrkB-FL, preserva las vías de señalización prosupervivencia y reduce la neurodegeneración y la sinaptopatía coclear. Además, a pesar de la existencia de un dimorfismo sexual en la susceptibilidad al daño por ruido in vivo, MTFL457 preserva la función auditiva y la integridad sináptica, lo que pone de manifiesto su potencial terapéutico para la NIHL y, posiblemente, para otros tipos de pérdida auditiva neurosensorial igualmente asociados con procesos de excitotoxicidad., This research was funded by an Industrial Doctorate project (IND2020/BMD-17454) from Comunidad de Madrid, with the participation of Alodia Farmacéutica S.L., and by MICIU/AEI/10.13039/501100011033/FEDER, UE, as part of projects PID2022-137710OB-I00 granted to Margarita Díaz-Guerra and PID2023−147347OB-I00 granted to Isabel Varela-Nieto., Peer reviewed